Experienced in Cardiogenic Shock

Dr. Christopher U. Meduri

Interventional Cardiology | Emergency Medicine
Stern Cardiovascular Foundation, Inc
8060 Wolf River Blvd, 
Germantown, TN 
Clinical Trials:Currently Recruiting for 2 Trials
Experienced in Cardiogenic Shock
Stern Cardiovascular Foundation, Inc
8060 Wolf River Blvd, 
Germantown, TN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Christopher Meduri is an Interventional Cardiologist and an Emergency Medicine provider in Germantown, Tennessee. Dr. Meduri is rated as an Experienced provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Supravalvular Aortic Stenosis, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

His clinical research consists of co-authoring 48 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Interventional Cardiology
Emergency Medicine
Licenses
Internal Medicine in NC
Hospital Affiliations
Baptist Memorial Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

STERN CARDIOVASCULAR FOUNDATION, INC
8060 Wolf River Blvd, Germantown, TN 38138

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO Trial
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO Trial
Enrollment Status: Recruiting
Publish Date: December 15, 2025
Intervention Type: Device
Study Phase: Not Applicable
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: May 21, 2025
Intervention Type: Device
Study Phase: Not Applicable
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
Enrollment Status: Active_not_recruiting
Publish Date: December 10, 2025
Intervention Type: Device
Study Phase: Not Applicable
Percutaneous MitraClip Device or Surgical Mitral Valve REpair in PAtients With PrImaRy MItral Regurgitation Who Are Candidates for Surgery (REPAIR MR)
Percutaneous MitraClip Device or Surgical Mitral Valve REpair in PAtients With PrImaRy MItral Regurgitation Who Are Candidates for Surgery (REPAIR MR)
Enrollment Status: Active_not_recruiting
Publish Date: November 12, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Transcatheter Aortic Valve Replacement (TAVR) With Medtronic TAVR System in Patients With Severe Bicuspid Aortic Valve Stenosis and at Low Predicted Risk of Mortality With Surgical Aortic Valve Replacement (SAVR)
Transcatheter Aortic Valve Replacement (TAVR) With Medtronic TAVR System in Patients With Severe Bicuspid Aortic Valve Stenosis and at Low Predicted Risk of Mortality With Surgical Aortic Valve Replacement (SAVR)
Enrollment Status: Active_not_recruiting
Publish Date: October 21, 2025
Intervention Type: Device
Study Phase: Not Applicable
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Enrollment Status: Active_not_recruiting
Publish Date: October 21, 2025
Intervention Type: Device
Study Phase: Not Applicable
Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid Valve Repair System Pivotal
Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid Valve Repair System Pivotal
Enrollment Status: Active_not_recruiting
Publish Date: December 19, 2024
Intervention Type: Device
Study Phase: Not Applicable
Early Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System
Early Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System
Enrollment Status: Terminated
Publish Date: August 06, 2024
Intervention Type: Device
Study Phase: Not Applicable
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Enrollment Status: Completed
Publish Date: October 10, 2023
Intervention Type: Device
Study Phase: Not Applicable
THE ALIGN-AR TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)
THE ALIGN-AR TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)
Enrollment Status: Active_not_recruiting
Publish Date: November 18, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Heart Valve System in the Treatment of High Surgical Risk Patients With Symptomatic, Severe Aortic Regurgitation (AR)
A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Heart Valve System in the Treatment of High Surgical Risk Patients With Symptomatic, Severe Aortic Regurgitation (AR)
Enrollment Status: Active_not_recruiting
Publish Date: September 13, 2022
Intervention Type: Device
Study Phase: Not Applicable
View 9 Less Clinical Trials

48 Total Publications

Thirty-day outcomes of a novel biomimetic balloon-expandable transcatheter heart valve in patients with small aortic annuli.
Thirty-day outcomes of a novel biomimetic balloon-expandable transcatheter heart valve in patients with small aortic annuli.
Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: November 18, 2025
Similar Doctors
Advanced in Cardiogenic Shock
Dr. Arsalan T. Shirwany
Interventional Cardiology | Interventional Radiology | Cardiology
Advanced in Cardiogenic Shock
Dr. Arsalan T. Shirwany
Interventional Cardiology | Interventional Radiology | Cardiology

Stern Cardiovascular Foundation, Inc

391 Southcrest Cir, Suite 200, 
Southaven, MS 
 (15.1 miles away)
901-271-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Arsalan Shirwany is an Interventional Cardiologist and an Interventional Radiologist in Southaven, Mississippi. Dr. Shirwany is rated as a Distinguished provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Angina, Endoscopy, and Heart Bypass Surgery. Dr. Shirwany is currently accepting new patients.

Advanced in Cardiogenic Shock
Dr. Justin A. May
Interventional Cardiology | Emergency Medicine
Advanced in Cardiogenic Shock
Dr. Justin A. May
Interventional Cardiology | Emergency Medicine

Stern Cardiovascular Foundation, Inc

100 Baptist Memorial Cir, Suite 201, 
Oxford, MS 
 (54.8 miles away)
901-271-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Justin May is an Interventional Cardiologist and an Emergency Medicine provider in Oxford, Mississippi. Dr. May is rated as a Distinguished provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Angina, Heart Attack, and Pacemaker Implantation. Dr. May is currently accepting new patients.

Advanced in Cardiogenic Shock
Dr. Osama M. Mahmoud
Advanced Heart Failure and Transplant Cardiology | Interventional Cardiology
Advanced in Cardiogenic Shock
Dr. Osama M. Mahmoud
Advanced Heart Failure and Transplant Cardiology | Interventional Cardiology

Stern Cardiovascular Foundation, Inc

6025 Walnut Grove, Suite 111, 
Memphis, TN 
 (4.0 miles away)
901-271-1000
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

Osama Mahmoud is an Advanced Heart Failure and Transplant Cardiologist and an Interventional Cardiologist in Memphis, Tennessee. Dr. Mahmoud is rated as an Advanced provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Pulmonary Edema, Cardiogenic Shock, Pulmonary Veno-Occlusive Disease, and Pulmonary Hypertension. Dr. Mahmoud is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Meduri's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile